Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Gastroenterologists who Treat GERD(?)

Council Members in this Study Group: 367

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Miguel Rodriguez, MD
Hepatologist and Gastroenterologist
Miami Gastroenterology Consultants PA

Miguel Rodriguez, MD, is a Hepatologist & Gastroenterologist, Managing Partner of Miami Gastroenterology Consultants, PA., a single specialty group in Miami, Florida. He is former Assistant Professor of Medicine of the University of Miami School of Medicine and Center for Liver Diseases and Division...

Carlos Dujovne, MD, Professor of Medicine and Director, OREGON HEALTH & SCIENCE UNIVERSITY - CCCarlos Dujovne, MD
Professor of Medicine and Director
OREGON HEALTH & SCIENCE UNIVERSITY - CC

Carlos Dujovne, MD, is an Internist, Gastroenterologist, Clinical Pharmacologist, Certified Clinical Lipidologist, Fr. Prof. of Medicine and Pharmacology, and Director of Clinical Pharmacology's Lipid-Arteriosclerosis Prevention-Treatment Clinic in Dept. of Medicine and Pharmacology at University of...

Michael Blume, Gastroenterologist, Metropolitan Medical AssociatesMichael Blume
Gastroenterologist
Metropolitan Medical Associates

Michael Blume, MD, is a Gastroenterologist at the Metropolitan Medical Associates in Baltimore, Maryland. In addition to being in full-time private practice, he has extensive experience in utilization management and quality improvement. Dr. Blume has done consulting work for various clinical efficiency...

Stefan Schreiber, MD
Professor
Christian-Albrechts-Universitat zu Kiel

Stefan Schreiber, MD, is Professor of Medicine and Gastroenterology at the Christian-Albrechts-University in Germany. Dr. Schreiber is responsible for designing, organizing, and conducting phase IB-III clinical trials of novel drugs for inflammatory bowel disease and the functional disorders of the...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

High blood acetaldehyde levels are associated with more liver and perhaps pancreatic damage and inflammation thus enhancing neoplasia. How would high blood acetaldehyde levels induce colorectal cancer? Also through inflammation. The alcohol dehydrogenase polymorphism is common in Asians yet there is...

Previous 'simple' molecular tests for cancer have ussually not worked out in practice. Although microRNA's have cellular control function for multiple genes it is premature to believe that these tests will be more successful.

By Carlos Dujovne, MD, Professor of Medicine and Director, OREGON HEALTH & SCIENCE UNIVERSITY - CC

1:Crestor is the most potent statin in the market,yet is 3d in sales behind Zocor and Lipitor.2:The efficacy supriority together with its capacity to lower CRP levels led to the highest rate of ASCVD prevention in the shortest period of time evr documented in statin trials.3:The trial in near 18,000...

The best epidemiologic data states that the incidence of colorectal cancer as well as most other cancers falls drammatically after age 85. Thus screening for a dissappearing disease makes no sense. Also colorectal cancer takes an average of 8-10 years to develop so that screening for average risk individuals...

By Carlos Dujovne, MD, Professor of Medicine and Director, OREGON HEALTH & SCIENCE UNIVERSITY - CC
Analysis of: Many Trial Reports on FDA-Approved Drugs Go Unpublished | www.washingtonpost.com

This article is not news for clinical researchers like myself that have performed hundreds of clinical trials in collaboration with the Pharmaceutical Industry. Some of the most common reasons for that are: A)Negative studies are difficult to get published.B)Negative results for the dug of the...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Academic Institution*
  • Non-Academic Community Hospital or Clinic
  • Government/Military Hospital or Clinic

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Division Head
  • Physician - Director
  • Owner
  • Partner
  • Professor

GLG's 850+ Clients Include:

Fortune 500®  companies
40 of the leading 50  global mutual funds
15 of the leading 20  global banks
8 of the leading 10  global private equity firms
5 of the top 10  AmLaw firms

Analytics


Generated at 2009-01-08T19:00:17.880